Funding Opportunities

• Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R01 - Clinical Trial Optional)
  (PA-18-790)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 5, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Patient Safety in the Context of Perinatal, Neonatal, and Pediatric Care (R03 - Clinical Trial Optional)
  (PA-18-791)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is October 16, 2018. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Advancing Evidence into Practice through Shared, Interoperable Clinical Decision Support Resources (U18)
  (PA-18-792)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• AHRQ Health Services Research Demonstration and Dissemination Grants (R18)
  (PA-18-793)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• AHRQ Small Research Grant Program (R03)
  (PA-18-794)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Standard dates apply), by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• AHRQ Health Services Research Projects (R01)
  (PA-18-795)
  Agency for Healthcare Research and Quality
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Computational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
  (PAR-18-796)
  National Library of Medicine
  Application Receipt Date(s): August 15, 2018; January 31, 2019; July 31, 2019; January 31, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• NIOSH Small Research Grant Program
  (PAR-18-797)
  Centers for Disease Control and Prevention
  Application Receipt Date(s): July 19, 2018 for New applications; August 10, 2018 for Resubmission and Revision applications. Standard dates apply for future due dates. Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NIOSH Exploratory/Developmental Grant Program (R21)
  (PAR-18-798)
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): July 19, 2018 for New Applications; August 10, 2018 for Resubmission and Revision applications. Standard Dates apply for future dates. Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• K01 Mentored Research Scientist Development Award
  (PAR-18-799)
  Centers for Disease Control and Prevention
  Application Receipt Date(s): July 19, 2018 for New applications; August 10, 2018 for Resubmission and Revision applications. Standard dates apply for future due dates. Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Biomarkers Discovery In Parkinsonism (U01 Clinical Trial Optional)
  (PAR-18-800)
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 6, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
• Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)
  (PAR-18-801)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)
  (PAR-18-802)
  National Cancer Institute
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. *** Note new SBIR/STTR Standard Due Dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NIH Directors New Innovator Award Program (DP2 - Clinical Trial Optional)
  (RFA-RM-18-008)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 10, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement?.
• NIH Directors Transformative Research Award (R01 - Clinical Trial Optional)
  (RFA-RM-18-009)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 21, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement.